Fareva SIMS

Fareva SIMS is a specialized contract development and manufacturing organization (CDMO) that focuses on the production of high-potency active pharmaceutical ingredients (HPAPIs). Located in Saint-Quentin-Fallavier, France, the facility is recognized as a center of excellence for the chemical synthesis of steroids and hormonal substances. Originally established as a manufacturing site for Pfizer (formerly Upjohn), it was acquired by the Fareva Group in 2004 to enhance its global chemical production capabilities. The company provides a range of services from process optimization and pilot-scale development to full-scale industrial manufacturing under strict Good Manufacturing Practice (GMP) standards. Fareva SIMS serves major pharmaceutical clients globally, supporting the supply chain for treatments in endocrinology and inflammatory diseases.